{
  "docId": "019de076-77d9-73e5-9074-4c77c1655c6b",
  "docSlug": "0575fd43545b2f1c002af8f3f4dd1051",
  "documentTitle": "argenx SE | Investor Presentation Deck | 9 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 9,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide presents a clinical trial outcome summary for the ADDRESS study.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-77d9-73e5-9074-4c77c1655c6b/7",
  "deckHref": "/decks/019de076-77d9-73e5-9074-4c77c1655c6b",
  "deckJsonHref": "/decks/019de076-77d9-73e5-9074-4c77c1655c6b.json",
  "deckAnchorHref": "/decks/019de076-77d9-73e5-9074-4c77c1655c6b#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.42,
        "x": 0.54,
        "y": 0.23
      },
      "kind": "list",
      "text": "Efficacy: Study did not meet primary or secondary endpoints. Safety: Well-tolerated and consistent with confirmed safety profile of VYVGART and VYVGART Hytrulo. PD Effect: Both efgartigimod SC and corticosteroids reduced autoantibody levels.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49b7ff15-b983-418f-89c1-a9cbc15ddc80",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.41,
        "x": 0.06,
        "y": 0.21
      },
      "kind": "table",
      "text": "Primary Endpoint Analysis % Sustained CRmin Treated 35.5% 44/124 Placebo 30.3% 20/66",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8dd9c3fa-215d-4dbf-8803-e38fffb1b1ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.33,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "ADDRESS Topline Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "83bd3f44-cbc6-4fc8-89ec-5c94b435315f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 7,
      "beatId": "8a99b154-169e-4253-8ce4-c46e98d2008e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The ADDRESS Topline Results and Sustained Growth Across Business provide satisfaction with the progress made.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}